Support for the role of the CX3CL1-CX3CR1 pathway in psychiatric disorders comes from a meta-analysis of microarray data demonstrating a significant decrease in CX3CR1 expression in the postmortem brain and blood of individuals with schizophrenia [113]. This evidence concerns the gene CX3CR1 and psychiatric disorder.